NCT03905421Completed
Quality of Life Assessed With the PAH SYMPACT Questionnaire
Quality of Life Assessed With the PAH SYMPACT Questionnaire in the Pulmonary Hypertension Clinic
Source: ClinicalTrials.gov · Last updated 25 Jul 2025
Brief summary (registry, in English)
Researchers are evaluating quality of life in pulmonary hypertension subjects using the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT) Questionnaire and assessing the questionnaires' performance with regard to relationship to other markers of disease severity, response to treatment, and outcome in a clinical practice setting.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 390 (actual)
- First submitted
- 13 Mar 2019
- Start date
- 6 Mar 2019
- Primary completion date
- 22 Jan 2024
- Lead sponsor
- Mayo Clinic
- NCT number
- NCT03905421
What you commit to
- Study type: Observational
- Participants enrolled: 390
- From 6 Mar 2019 to the primary completion date, 22 Jan 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Any other known concomitant life-threatening disease with a life expectancy \<12 months
Other illness
- Any other clinically relevant and/or serious chronic medical condition that would affect study participation in the opinion of the investigator
Lab values
- Left sided heart disease (LVEF\<50%, PAWP\>18)
Other
- Non English speaking
Who the study is looking for
- Age 18 years or above
- Consents to participate
- Documented group I PAH based upon these hemodynamic criteria: (mPAP \> 20, PCW 18 or less, PVR \> 3 Wood units
- Mean PAP \> 20, PCW ≤ 18, PVR \> 3 Wood units
- Parenchymal lung disease that in the opinion of the investigator qualifies patient as group III PH
- Documented chronic thromboembolic pulmonary hypertension or chronic thromboembolic disease with intent to treat with surgery, balloon pulmonary angioplasty, and/or PH medication
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Mayo Clinic in Rochester Coordinator of this site? Confirm its status | Rochester | United States | Unknown status |
Related publications
This page is information, not medical advice. Discuss any trial with your doctor.